Potential new treatment for cocaine addiction

August 31, 2016
A pile of cocaine hydrochloride. Credit: DEA Drug Enforcement Agency, public domain

A team of researchers led by Cardiff University has discovered a promising new drug treatment for cocaine addiction.

The , which involves administering a currently used in cancer therapy trials, treats cocaine addiction by inhibiting memories responsible for cravings.

Professor Riccardo Brambilla from Cardiff University's School of Biosciences said: "We have demonstrated that a single administration of a trial drug from the pharmacompany Pfizer can completely obliterate cocaine associated memories and significantly accelerate the end of drug seeking behaviour in animals. With this drug currently being used in cancer trials, it could be easily repositioned for treatment of and other drugs of abuse."

Cocaine produces its partially by acting on the brain's limbic system - a set of interconnected regions that regulate pleasure and motivation. When a person uses cocaine, memories of the intense pleasure felt and the things associated with it are newly created. It is these long lasting memories and drug-associated cues, key to the transition from recreational drug taking to compulsive drug use, which the new treatment inhibited when tested on mice.

Dr Stefania Fasano from Cardiff University added, "With drug use recently on the rise, new treatments for breaking addiction are much needed. The availability of a powerful drug from Pfizer, already validated in humans, could speed up the clinical development of our findings."

The research is published in the journal eLife.

This was an experimental study in mice, which allows for conclusions to be made about cause and effect in this species. To learn about the effect of this treatment in people experimental trials with humans will be necessary.

Explore further: Study using animal model provides clues to why cocaine is so addictive

More information: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors; eLife 2016;5:e17111; DOI: dx.doi.org/
10.7554/eLife.17111

Related Stories

Scientists show molecule in brain may drive cocaine addiction

August 10, 2016

A new study from scientists at The Scripps Research Institute (TSRI), funded by the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA), ...

New role for glial energy metabolism in addiction

June 9, 2016

Addiction may be viewed as a disorder of reward learning. To date, addiction research has focused on the molecular adaptations through which memories of exposure to abused substances are encoded and maintained by nerve cells.

Addiction silences synapses in reward circuits

August 2, 2016

In addiction, cues in the environment can form strong associations with the drug of abuse. A new study in Biological Psychiatry suggests that alterations in silent synapses, inactive connections between neurons, could be ...

Recommended for you

Alcoholics may lack key enzyme

September 22, 2016

(HealthDay)—Alcoholics may lack an enzyme that would help them control their impulse to drink, a new study with rats suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.